p-Tolylsulfanyl-acetic acid ethyl ester, 99.0%, 25g

4-Methoxy-2,2-dimethyl-4-oxobutanoic acid, 95%, 100mg

Sofosbuvir impurity F, 1mg

Chlorobenzene, min 99.5%, for synthesis, 1L, glass packaging

14-Bromo-1-tetradecanol, 95.0%, 25g

3-(4-Methoxy-3-methylphenyl)propanoic acid, 98%, 1g

2-Amino-3-(thiophen-2-yl)propanoic acid, 95.0%, 25g

4-(Trifluoromethyl)-dl-phenylalanine, 97.0%, 250mg

Pyridine-2-carboximidamide hydrochloride, 97.0%, 500g

4-Bromo-2,6-dimethoxyphenol, 95+%, 1g

1,5-Diethynyl-2,4-dimethylbenzene>98.0%(GC)1g

N-(2,4-Dimethoxybenzyl)-5-fluoro-N-(6-fluoropyridin-2-yl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 97%, 25mg

tert-Butyl 3-(trifluoromethyl)-4,5-dihydro-1H-pyrazolo[3,4-c]pyridine-6(7H)-carboxylate, 95.0%, 1g